These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1453987)

  • 21. In vitro activity and killing effect of uperin 3.6 against gram-positive cocci isolated from immunocompromised patients.
    Giacometti A; Cirioni O; Kamysz W; Silvestri C; Licci A; D'Amato G; Nadolski P; Riva A; Lukasiak J; Scalise G
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3933-6. PubMed ID: 16127075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vitro study of the effects of an imipenem-fosfomycin combination against clinical strains of Staphylococcus].
    Fosse T; David MF; Duluc F
    Pathol Biol (Paris); 1986 Dec; 34(10):1055-9. PubMed ID: 3547260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative activity of garenoxacin and other agents by susceptibility and time-kill testing against Staphylococcus aureus, Streptococcus pyogenes and respiratory pathogens.
    Noviello S; Ianniello F; Leone S; Esposito S
    J Antimicrob Chemother; 2003 Nov; 52(5):869-72. PubMed ID: 14519672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro brodimoprim activity on nosocomial bacterial strains.
    Nicoletti P; Novelli A; Periti P
    J Chemother; 1993 Dec; 5(6):430-4. PubMed ID: 8195834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria.
    Kastoris AC; Rafailidis PI; Vouloumanou EK; Gkegkes ID; Falagas ME
    Eur J Clin Pharmacol; 2010 Apr; 66(4):359-68. PubMed ID: 20186407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical efficacy of fosfomycin combinations against a variety of gram-positive cocci.
    Coronado-Álvarez NM; Parra D; Parra-Ruiz J
    Enferm Infecc Microbiol Clin (Engl Ed); 2019 Jan; 37(1):4-10. PubMed ID: 29907368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In-vitro antibacterial activity of fusidic acid alone and in combination with other antibiotics against methicillin-sensitive and -resistant Staphylococcus aureus.
    Drugeon HB; Caillon J; Juvin ME
    J Antimicrob Chemother; 1994 Dec; 34(6):899-907. PubMed ID: 7730233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of aurein 1.2 alone and in combination with antibiotics against gram-positive nosocomial cocci.
    Giacometti A; Cirioni O; Riva A; Kamysz W; Silvestri C; Nadolski P; Della Vittoria A; Łukasiak J; Scalise G
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1494-6. PubMed ID: 17220421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of different combinations of sparfloxacin, oxacillin, and fosfomycin against methicillin-resistant staphylococci.
    Ferrara A; Dos Santos C; Cimbro M; Gialdroni Grassi G
    Eur J Clin Microbiol Infect Dis; 1997 Jul; 16(7):535-7. PubMed ID: 9272391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [In vitro effects of combinations of antibiotics against highly-fosfomycin-resistant, methicillin-resistant Staphylococcus aureus. With special reference to efficacies of combinations of imipenem/cilastatin and cephems].
    Kouda M
    Jpn J Antibiot; 1993 Feb; 46(2):142-53. PubMed ID: 8331774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of LY333328 (oritavancin) against Gram-positive aerobic cocci and synergy with ciprofloxacin against enterococci.
    Noviello S; Ianniello F; Esposito S
    J Antimicrob Chemother; 2001 Aug; 48(2):283-6. PubMed ID: 11481302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of imipenem against enterococci and staphylococci and evidence for high rates of synergism with teicoplanin, fosfomycin, and rifampin.
    Debbia E; Varaldo PE; Schito GC
    Antimicrob Agents Chemother; 1986 Nov; 30(5):813-5. PubMed ID: 2948444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The in-vitro activity of RP 59500 against gram-positive cocci.
    Goto S; Miyazaki S; Kaneko Y
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():25-8. PubMed ID: 1399947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergism between ciprofloxacin and fosfomycin against gram-negative bacteria in vitro.
    Vogt K; Hahn H
    Zentralbl Bakteriol; 1989 Dec; 272(2):225-30. PubMed ID: 2631736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibility of frequent urinary pathogens to fosfomycin trometamol and eight other antibiotics: results of an Italian multicenter survey.
    Schito GC; Chezzi C; Nicoletti G; Moreddu M; Arcangeletti MC; Stefani S; Albini E; Del Bono GP
    Infection; 1992; 20 Suppl 4():S291-5. PubMed ID: 1294520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Synergic action of the combination of fosfomycin and kanendomycin against gram-positive and gram-negative bacteria].
    Russo G; Toscano MA; Gismondo MR; Nicolosi V; Garaci E
    Ann Sclavo; 1980; 22(1):77-82. PubMed ID: 7247487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of gram positive cocci isolated from urine.
    Mathai E; Margaret A; George V; Brahmadathan KN
    Indian J Med Res; 1994 Jul; 100():10-4. PubMed ID: 7927545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ciprofloxacin, imipenem and rifampicin: in-vitro synergy of two and three drug combinations against Pseudomonas cepacia.
    Kumar A; Wofford-McQueen R; Gordon RC
    J Antimicrob Chemother; 1989 Jun; 23(6):831-5. PubMed ID: 2759929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [In vitro antibacterial activity of a halogenated derivative of D-alanine].
    Viano I; Santiano M; Savoia D
    G Batteriol Virol Immunol; 1979; 72(1-6):134-42. PubMed ID: 121980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fosfomycin.
    Falagas ME; Vouloumanou EK; Samonis G; Vardakas KZ
    Clin Microbiol Rev; 2016 Apr; 29(2):321-47. PubMed ID: 26960938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.